SBS 406
Alternative Names: SBS-406Latest Information Update: 04 Dec 2023
Price :
$50 *
At a glance
- Originator Washington University School of Medicine
- Developer Sparian Biosciences
- Class Analgesics
- Mechanism of Action Opioid delta receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neuropathic pain
Most Recent Events
- 04 Dec 2023 Discontinued - Preclinical for Neuropathic pain in USA (unspecified route) (Sparian Biosciences pipeline, November 2023)
- 21 Feb 2023 Preclinical trials in Neuropathic pain in USA (unspecified route) (Sparian Biosciences pipeline, February 2023)